Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means the agency’s own highest classification or reported deaths or serious injuries, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
Grandpa Brands Co is recalling Dent's Extra Strength Toothache Gum due to superpotent benzocaine levels. Consumers should stop using the product.
Stat Rx USA is recalling 51 bottles of Tizanidine 4 mg tablets because some labels incorrectly identified Actavis as the manufacturer.
Fougera Pharmaceuticals is recalling 444 bottles of Erythromycin Topical Solution USP, 2%, due to potential trace contamination with Di-Octyl Phthalate.
Hospira Inc. is recalling Morphine Sulfate Injection cartridges that contain 2.2 mL instead of the labeled 1 mL, posing a risk of overdose.
Luitpold Pharmaceuticals is recalling Epinephrine Injection ampules because of the presence of particulate matter. The affected lot was distributed nationwide.
Meda Pharmaceuticals is recalling Prefera OB One Gel Capsules because the product labeling failed to list several inactive ingredients, including D&C Red #33.
Pack Pharmaceuticals is voluntarily recalling 4,848 bottles of Ciprofloxacin 500 mg tablets because two bottles were found missing container labels.
Vintage Pharmaceuticals is recalling 73,746 bottles of Hydroxyzine Hydrochloride Oral Solution because high levels of a known impurity were detected.
JHP Pharmaceuticals is recalling specific lots of Pitocin (Oxytocin) injection due to a labeling error that displays an incorrect lower storage temperature limit.
Bayer is recalling 119,412 cartons of Midol Complete because the blister strip label does not match the carton regarding the maximum daily dose.
Bayer Healthcare is recalling 48,528 cartons of Midol Complete because the maximum daily dose stated on the blister strip does not match the carton label.
Noven Pharmaceuticals is recalling Daytrana (methylphenidate) transdermal patches because the delivery system is miscalibrated or defective, potentially affecting drug delivery.
GlaxoSmithKline is recalling Trizivir tablets because they may contain foreign Lexiva tablets. Patients should stop using the affected lot and contact their healthcare provider.
VistaPharm is recalling specific lots of Hydrocodone Bitartrate & Acetaminophen Oral Solution because impurities exceeded specifications during stability testing.
AstraZeneca is recalling 2,556 bottles of Nexium 40 mg capsules because some may contain Nexium 20 mg capsules intended for the Japanese market.
Vintage Pharmaceuticals is recalling 54,431 bottles of Hydrocortisone and Acetic Acid Otic Solution because impurity levels exceeded specifications.
Teva Pharmaceuticals is recalling 2,268 bottles of Metoprolol Tartrate 50 mg tablets in Ohio because some tablets may not meet weight specifications.
Sanofi-aventis is recalling 196,355 vials of Eloxatin (oxaliplatin) injection nationwide because the contract manufacturer failed to meet Good Manufacturing Practices.
Sanofi-aventis is recalling Eloxatin (oxaliplatin) injection vials because the contract manufacturer had significant Good Manufacturing Practice issues.
Watson Laboratories is recalling 7,262 bottles of Loxapine Succinate Capsules because an outdated patient outsert was used during packaging.
Ranbaxy Inc. is recalling Balnetar Therapeutic Tar Bath, Coal Tar USP 2.5%, because the product failed to meet specifications for coal tar content.
Watson Laboratories Inc. is recalling Loxapine Capsules because an outdated version of the patient outsert was used during packaging.
Watson Laboratories is recalling 8,254 bottles of Loxapine Capsules 5mg because an outdated patient outsert was used during packaging.
Watson Laboratories Inc. is recalling Loxapine Capsules because an outdated patient outsert was used during packaging.
Watson Laboratories is recalling 18,902 bottles of Loxapine 50mg capsules because an outdated patient outsert was used during packaging.